BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2881447)

  • 1. Cognitive impairments in Parkinson's disease.
    Growdon JH; Corkin S
    Adv Neurol; 1987; 45():383-92. PubMed ID: 2881447
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinctive aspects of cognitive dysfunction in Parkinson's disease.
    Growdon JH; Corkin S; Rosen TJ
    Adv Neurol; 1990; 53():365-76. PubMed ID: 1978518
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease.
    Lee SJ; Kim JS; Yoo JY; Song IU; Kim BS; Jung SL; Yang DW; Kim YI; Jeong DS; Lee KS
    Alzheimer Dis Assoc Disord; 2010; 24(3):227-33. PubMed ID: 20473133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What causes mental dysfunction in Parkinson's disease?
    Emre M
    Mov Disord; 2003 Sep; 18 Suppl 6():S63-71. PubMed ID: 14502658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual impairment in Parkinson's disease.
    Stern Y; Mayeux R
    Adv Neurol; 1987; 45():405-8. PubMed ID: 3825716
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mysterious cognitive disorder of Parkinson disease.
    Mortimer JA
    Alzheimer Dis Assoc Disord; 1990; 4(3):129-32. PubMed ID: 2223019
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for cognitive deterioration and dementia in Parkinson's disease.
    Portin R; Rinne UK
    Adv Neurol; 1987; 45():413-6. PubMed ID: 3825718
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive estimation in patients with early subcortical vascular dementia.
    Billino J; Brand M; Roesler A
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):982-3. PubMed ID: 18214997
    [No Abstract]   [Full Text] [Related]  

  • 12. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Alzheimer lesions in Parkinson's disease.
    Jellinger KA
    Mov Disord; 2003 Oct; 18(10):1207-8. PubMed ID: 14534932
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
    Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
    Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia of Parkinson's disease.
    Korczyn AD; Inzelberg R; Treves T; Neufeld M; Reider I; Rabey PM
    Adv Neurol; 1987; 45():399-403. PubMed ID: 3825715
    [No Abstract]   [Full Text] [Related]  

  • 16. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive and behavioral disorders in Parkinson disease].
    Pascual-Leone A; Press D
    Rev Neurol; 1999 Jul 16-31; 29(2):152-7. PubMed ID: 10528330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric findings in clinical subtypes of Parkinson's disease.
    Ransmayr G; Poewe W; Ploerer S; Birbamer G; Gerstenbrand F
    Adv Neurol; 1987; 45():409-11. PubMed ID: 3825717
    [No Abstract]   [Full Text] [Related]  

  • 20. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.